Frank Pallone (Kevin Dietsch/Pool via AP Images)
August 20, 2021 06:38 AM EDT
Pharma

House com­mit­tee ques­tions Eli Lil­ly, Sanofi and No­vo Nordisk as in­sulin prices re­main 'u­nac­cept­ably high'

Zachary Brennan

Senior Editor

House En­er­gy & Com­merce Com­mit­tee lead­ers sent three let­ters on Thurs­day to ex­ecs at Eli Lil­ly,

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times